24 Aug 2023 In 1H23, Vincent Medical’s (
CROSBY Research – Vincent Medical (1612 HK/BUY): Staging a turnaround in 1H23
CROSBY Research – Pagoda (2411 HK): Widening NPM on operational efficiency and cost savings
22 Aug 2023 The company reported a 6.4%
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 41)
21 Aug 2023 Hong Kong’s population
CROSBY Research – China Lilang (1234 HK): Single digit growth in 1H23
18 Aug 2023 The company reported a 6.7%
CROSBY Research – 361 Degrees (1361 HK/BUY): Promising outlook
17 Aug 2023 1H23 revenue increased by 18
CROSBY Research – Pentamaster (1665 HK/BUY): Steady 2Q23 revenue growth, medical devices will drive 2H23 momentum
16 Aug 2023 Pentamaster’s 2Q23 revenue i
CROSBY Research – Greentech(1257 HK/BUY): Increasing EBITDA for its biomass segment
15 Aug 2023 CEG’s 1H23 revenue was down
CROSBY Research – SIIC (807 HK): Growth driven by the new Baoshan project
14 Aug 2023 SIIC’s 1H23 revenue increase
CROSBY Research – Q-Tech (1478 HK/BUY): Expect the recovery trajectory to maintain in 2H23, maintain BUY rating
11 Aug 2023 Q-Tech reported 1H23 revenue
CROSBY Research – TMT sector: Review of 2Q23 smartphone shipment and market share
07 Aug 2023 According to the latest data